APA (7th ed.) Citation

Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J., . . . Lepage, C. (2014). Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): An open-label, randomised phase 3 trial. The lancet oncology, 15(8), 862-873. https://doi.org/10.1016/S1470-2045(14)70227-X

Chicago Style (17th ed.) Citation

Taieb, Julien, et al. "Oxaliplatin, Fluorouracil, and Leucovorin with or Without Cetuximab in Patients with Resected Stage III Colon Cancer (PETACC-8): An Open-label, Randomised Phase 3 Trial." The Lancet Oncology 15, no. 8 (2014): 862-873. https://doi.org/10.1016/S1470-2045(14)70227-X.

MLA (9th ed.) Citation

Taieb, Julien, et al. "Oxaliplatin, Fluorouracil, and Leucovorin with or Without Cetuximab in Patients with Resected Stage III Colon Cancer (PETACC-8): An Open-label, Randomised Phase 3 Trial." The Lancet Oncology, vol. 15, no. 8, 2014, pp. 862-873, https://doi.org/10.1016/S1470-2045(14)70227-X.